Company Registration No. 05890213 (England and Wales)
Antidote Health Products Limited
Unaudited accounts
for the year ended 30 July 2025
Antidote Health Products Limited
Unaudited accounts
Contents
Antidote Health Products Limited
Company Information
for the year ended 30 July 2025
Secretary
Pamela Rani Chabba
Company Number
05890213 (England and Wales)
Registered Office
28 Stondon Park
London
SE23 1LA
England
Accountants
Abacus Accounting Solutions Ltd
5 Pasture Close
North Wembley
Middlesex
HA0 3JE
Antidote Health Products Limited
Statement of financial position
as at 30 July 2025
Creditors: amounts falling due within one year
(66,343)
(66,162)
Net current liabilities
(62,022)
(58,870)
Net liabilities
(62,022)
(58,870)
Called up share capital
1,000
1,000
Profit and loss account
(63,022)
(59,870)
Shareholders' funds
(62,022)
(58,870)
For the year ending 30 July 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 10 May 2026 and were signed on its behalf by
Malini Chabba
Director
Company Registration No. 05890213
Antidote Health Products Limited
Notes to the Accounts
for the year ended 30 July 2025
Antidote Health Products Limited is a private company, limited by shares, registered in England and Wales, registration number 05890213. The registered office is 28 Stondon Park, London, SE23 1LA, England.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous year, and also have been consistently applied within the same accounts.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
20% reducing balance
4
Tangible fixed assets
Plant & machinery
5
Creditors: amounts falling due within one year
2025
2024
Bank loans and overdrafts
2,193
4,120
Trade creditors
3,539
2,578
Taxes and social security
38
-
Other creditors
59,973
58,914
Antidote Health Products Limited
Notes to the Accounts
for the year ended 30 July 2025
6
Average number of employees
During the year the average number of employees was 1 (2024: 1).